FDA Determines Regulatory Review Period for RESOLUTE INTEGRITY ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

Summary

The US Food and Drug Administration (FDA) has officially approved the regulatory review period for the RESOLUTE INTEGRITY ZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM, a medical device, in accordance with federal regulations, following a patent extension application submitted to the US Patent and Trademark Office (USPTO).